Sep 08, 2023 / 02:15PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst
All right. Great. So thank you all for attending. I'm Tim Daley. I'm life science tools, diagnostics and pharma services analyst here at Wells Fargo. This is the final presentation for my track with -- for the Wells Fargo 2023 Healthcare Conference. So we are very pleased to be having the Repligen team here. We've got Tony Hunt, CEO.
Questions and Answers:
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate AnalystAnd a very interesting space, very dynamic, the last few quarters, I guess the last few years. So just really kind of just thinking about everybody is really focused on the inflection point, right? Much more so on the order dollar front. I think you guys have done -- been really helpful so far in helping us understand sequential order cadence on a dollar basis.
But just to think about August, this conference, we've been hearing slight improvement in tone around biotech. Nobody is willing to call it back or even say it's
Trustpilot
